Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Belgium
  4. Euronext Bruxelles
  5. Mithra Pharmaceuticals S.A.
  6. Summary
    MITRA   BE0974283153

MITHRA PHARMACEUTICALS S.A.

(MITRA)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Real-time Quote. Real-time Euronext Bruxelles
01/17/2022 01/18/2022 01/19/2022 01/20/2022 01/21/2022 Date
21.25(c) 21.15(c) 20.55(c) 21.1(c) 20.6 Last
133 492 67 985 71 957 160 456 50 278 Volume
-1.62% -0.47% -2.84% +2.68% -2.37% Change
More quotes
Estimated financial data (e)
Sales 2021 47,8 M 54,2 M 54,2 M
Net income 2021 -69,0 M -78,1 M -78,1 M
Net cash position 2021 121 M 138 M 138 M
P/E ratio 2021 -13,4x
Yield 2021 -
Sales 2022 274 M 310 M 310 M
Net income 2022 133 M 151 M 151 M
Net cash position 2022 98,6 M 112 M 112 M
P/E ratio 2022 4,96x
Yield 2022 -
Capitalization 929 M 1 054 M 1 053 M
EV / Sales 2021 16,9x
EV / Sales 2022 3,03x
Nbr of Employees 300
Free-Float 57,1%
More Financials
Company
Mithra Pharmaceuticals S.A. is a Belgian biotech company dedicated to transforming Women's Health by offering new choices through innovation, with a particular focus on contraception and menopause. Mithra's goal is to develop products offering better efficacy, safety and convenience, meeting women's needs throughout their life span. Mithra Pharmaceuticals S.A. explores the potential of the unique native estrogen... 
Sector
Pharmaceuticals
Calendar
03/03Earnings Release
More about the company
Ratings of Mithra Pharmaceuticals S.A.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C-
More Ratings
All news about MITHRA PHARMACEUTICALS S.A.
01/17Mithra Announces Positive Top-Line Results
AQ
01/14MITHRA PHARMACEUTICALS S A : Announces Positive Top-Line Results from Donesta« Phase 3 Stu..
PU
01/11Publication of a Transparency Notification Received from Francois Fornieri
AQ
01/10MITHRA PHARMACEUTICALS S A : Publication of a Transparency Notification Received from Fran..
PU
2021MITHRA PHARMACEUTICALS S A : Issues a Put Option Notice Under Capital Agreement with LDA C..
PU
2021Mayne pharma and mithra announce tga approval of nextstellis oral contraceptive
AQ
2021MITHRA PHARMACEUTICALS S A : Mayne Pharma and Mithra Announce TGA Approval of Nextstellis«..
PU
2021MITHRA PHARMACEUTICALS S A : holds today its Investor Day at CDMO
PU
2021Mayne Pharma Secures Australian Regulatory Approval for Oral Contraceptive
MT
2021Mithra organizes its Investor Day on November 29, 2021
PU
2021MITHRA PHARMACEUTICALS S A : Announces Estelle Launch in Belgium
AQ
2021MITHRA PHARMACEUTICALS S A : Announces Estelle« Launch in Belgium
PU
2021MITHRA PHARMACEUTICALS S A : The Board of Directors confirms Leon Van Rompay as Mithra's C..
PU
2021MITHRA PHARMACEUTICALS S A : Provides FDA Update on Myring
AQ
2021MAYNE PHARMA : Provides fda update on generic nuvaringo
AQ
More news
News in other languages on MITHRA PHARMACEUTICALS S.A.
01/20Kepler Cheuvreux verhoogt koersdoel Mithra
01/17Degroof Petercam verhoogt koersdoel Mithra
01/14Mithra zijn timing zit goed
01/14KBC Securities verhoogt koersdoel Mithra
01/14Mithra meldt positieve onderzoeksresultaten met Donesta
More news
Chart MITHRA PHARMACEUTICALS S.A.
Duration : Period :
Mithra Pharmaceuticals S.A. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MITHRA PHARMACEUTICALS S.A.
Short TermMid-TermLong Term
TrendsNeutralBullishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Last Close Price 21,10 €
Average target price 35,73 €
Spread / Average Target 69,3%
EPS Revisions
Managers and Directors
Leon van Rompay Chief Executive Officer
Christophe MarÚchal Chief Financial Officer
Ajit S. Shetty Chairman
Graham K. Dixon CSO, Head-Research & Development
Koen Hoffman Independent Director
Sector and Competitors
1st jan.Capi. (M$)
MITHRA PHARMACEUTICALS S.A.5.61%1 054
CSL LIMITED-6.70%94 348
WUXI BIOLOGICS (CAYMAN) INC.-1.30%49 439
SAMSUNG BIOLOGICS CO.,LTD.-9.63%45 416
ALEXION PHARMACEUTICALS, INC.0.00%40 336
BIOGEN INC.-5.84%33 185